Curator: Aviva Lev-Ari, PhD, RN
Sunitinib brings Adult acute lymphoblastic leukemia (ALL) to Remission – RNA Sequencing – FLT3 Receptor Blockade
REMISSION to Adult Acute Lymphoblastic Leukemia (ALL): Pfizer’s Sutent blocks FLT3 Gene Receptors
July 10, 2012 by 2012pharmaceutical
Posted in CANCER BIOLOGY & Innovations in Cancer Therapy, Genome Biology | Tagged DNA Sequencing, FLT3 gene on CHromosome 13, FLT3 receptor blockage, Pfizer, RNA sequencing, Suntinib, Sutent | 1 Comment
One Response
Leave a Reply Cancel reply
-
Recent Posts
- Personalized medicine and Colon cancer
- Imaging Biomarker for Arterial Stiffness: Pathways in Pharmacotherapy for Hypertension and Hypercholesterolemia Management
- The Implications of a Newly Discovered CYP2J2 Gene Polymorphism Associated with Coronary Vascular Disease in the Uygur Chinese Population
- Fraudulent Reviews on Amazon.com: Underground Economy where People are Paying for Online Reviews
- Cardio-Metabolic Drug Targets, Inaugural, September 25 – 26, 2013, Westin Waterfront | Boston, Massachusetts
Archives
Categories
- Advanced Drug Manufacturing Technology
- Alzheimer's Disease
- Aortic Valve: TAVI, TAVI vs Open Heart Surgery
- Atherogenic Processes & Pathology
- Bio Instrumentation in Experimental Life Sciences Research
- Biological Networks, Gene Regulation and Evolution
- Biomarkers & Medical Diagnostics
- BioSimilars
- Bone Disease and Musculoskeletal Disease
- CABG
- CANCER BIOLOGY & Innovations in Cancer Therapy
- Cancer Prevention: Research & Programs
- Cardiac & Vascular Repair Tools Subsegment
- Cardiovascular Pharmacogenomics
- Cell Biology, Signaling & Cell Circuits
- Cerebrovascular and Neurodegenerative Diseases
- Chemical Biology and its relations to Metabolic Disease
- Chemical Genetics
- Coagulation Therapy and Internal Bleeding
- Computational Biology/Systems and Bioinformatics
- Disease Biology, Small Molecules in Development of Therapeutic Drugs
- Drug Delivery Platform Technology
- Ecosystems & Industrial Concentration in the Medical Device Sector
- Etiology
- Exec Compensation in the Cardiac & Vascular Repair Tools Subsegment
- FDA Regulatory Affairs
- FDA, CE Mark & Global Regulatory Affairs: process management and strategic planning – GCP, GLP, ISO 14155
- Frontiers in Cardiology
- Genome Biology
- Genomic Endocrinology, Preimplantation Genetic Diagnosis and Reproductive Genomics
- Genomic Testing: Methodology for Diagnosis
- Glycobiology: Biopharmaceutical Production, Pharmacodynamics and Pharmacokinetics
- Health Economics and Outcomes Research
- Health Law & Patient Safety
- HealthCare IT
- HTN
- HTN in Youth
- Human Immune System in Health and in Disease
- Human Sensation and Cellular Transduction: Physiology and Therapeutics
- Imaging-based Cancer Patient Management
- Infectious Disease & New Antibiotic Targets
- Innovations in Neurophysiology & Neuropsychology
- International Global Work in Pharmaceutical
- Interviews with Scientific Leaders
- ISO 10993 for Product Registration: FDA & CE Mark for Development of Medical Devices and Diagnostics
- Liver & Digestive Diseases Research
- Massachusetts Niche Suppliers and National Leaders
- Medical and Population Genetics
- Medical Devices
- Medical Devices R&D Investment
- Medical Imaging Technology, Image Processing/Computing, MRI
- Metabolomics
- Mitral Valve: Repair and Replacement
- Molecular Genetics & Pharmaceutical
- Nanotechnology for Drug Delivery
- Nitric Oxide in Health and Disease
- Nutrigenomics
- Nutrition
- Nutritional Supplements: Atherogenesis, lipid metabolism
- Origins of Cardiovascular Disease
- Pain: Etiology, Genetics & Innovations in Treatment
- Patient Experience: Personal Memories of Invasive Medical Intervantion
- PCI
- Personalized Medicine & Genomic Research
- Pharmaceutical Analytics
- Pharmaceutical Industry Competitive Intelligence
- Pharmaceutical R&D Investment
- Pharmacogenomics
- Pharmacotherapy
- Pharmacotherapy of Cardiovascular Disease
- Population Health Management, Genetics & Pharmaceutical
- Population Health Management, Nutrition and Phytochemistry
- Procedures
- Proteomics
- Regulated Clinical Trials: Design, Methods, Components and IRB related issues
- Renal Denervation
- Reproductive Biology & Bio Instrumentation
- Resident-cell-based
- Scientist: Career considerations
- Statistical Methods for Research Evaluation
- Stem Cells for Regenerative Medicine
- Stents & Tools
- Systemic Inflammatory Response Related Disorders
- Technology Transfer: Biotech and Pharmaceutical
- Uncategorized
- Valves & Tools
Meta
[...] REMISSION to Adult Acute Lymphoblastic Leukemia (ALL): Pfizer’s Sutent blocks FLT3 Gene Receptors [...]